MOTS-c
A peptide from mitochondria, sometimes called an “exercise mimic” for its effects on metabolism.
Best value right now · 10 mg
Step One
IN STOCKUNTESTED
Per mg50% under the $5.00 median
Vial price10 mg · verified Aug 21
Avg per mg · 10 mg
$7.10−19.0%
Ranged $6.91 – $8.93 across 61 vendorsCompare 55 vendors · 10 mg
VendorStock
46
Welli LabsUNTESTED · OUT
$3.00$29.99
47
Ion PeptideUNTESTED · OUT
$4.20$42.00
48
Verified PeptidesUNTESTED · OUT
$4.30$43.00
49
PeptidologyTRUST 7.6 · OUT
$4.40$43.99
50
Royal PeptidesUNTESTED · OUT
$6.00$60.00
51
Onyx ResearchUNTESTED · OUT
$6.75$67.50
52
Behemoth LabzUNTESTED · OUT
$7.87$78.69
53
Genetic PeptideUNTESTED · OUT · 20% OFF
$8.80$88.00$110.00
54
Real PeptidesUNTESTED · OUT
$9.00$90.00
Showing 8 of 55 vendors · 47 more from $3.00/mg
MOTS-c prices verified Aug 21, 2026
$2.52/mgStep One · $25.20
Buy best pricePrice movement · 30 days
−6.6%median per mg, all sizes
Cheapest ever recorded: $0.721/mg on Aug 18. Today is 100.2% above that low.See our top-ranked MOTS-c vendors
Ranked by Finnrick trust score, independent lab testing, and price.
Compare MOTS-c head-to-head
- MOTS-c vs SS-31
- MOTS-c vs Epithalon
- MOTS-c vs NAD+
- MOTS-c vs FOXO4-DRI
- MOTS-c vs SLU-PP-332
- MOTS-c vs Humanin
Quick Summary
Often called 'exercise in a bottle' — a mitochondrial peptide that may mimic the metabolic benefits of working out. Available from 61 vendors, priced from $28.00 to $699.50.
Research: A MOTS-c analog completed Phase 1 trials in 20 obese patients with fatty liver, showing significant reductions in liver damage markers and decreased blood sugar after just 4 weeks.
Side effects: Injection site reactions, Increased heart rate, GI upset, Insomnia
Research compoundPhase 1 completed for analog CB4211
- 54 of 61 vendors currently have it in stock
- Highest-rated vendor: NUPEPS Peptides (9.0 Finnrick score)
- Most common vial size: 10mg
- Category: Metabolic / Longevity — Longevity, mitochondrial, and metabolic peptides
Get MOTS-c price alerts
Join the list — price-drop alerts for this peptide are in the works and you'll be first on them.